AU2003100271A4 - Chemical spot test for the detection of drugs of abuse in a beverage. - Google Patents
Chemical spot test for the detection of drugs of abuse in a beverage. Download PDFInfo
- Publication number
- AU2003100271A4 AU2003100271A4 AU2003100271A AU2003100271A AU2003100271A4 AU 2003100271 A4 AU2003100271 A4 AU 2003100271A4 AU 2003100271 A AU2003100271 A AU 2003100271A AU 2003100271 A AU2003100271 A AU 2003100271A AU 2003100271 A4 AU2003100271 A4 AU 2003100271A4
- Authority
- AU
- Australia
- Prior art keywords
- drugs
- abuse
- reagent
- beverage
- colorimetric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229940079593 drug Drugs 0.000 title claims description 19
- 239000003814 drug Substances 0.000 title claims description 19
- 235000013361 beverage Nutrition 0.000 title claims description 13
- 238000012360 testing method Methods 0.000 title claims description 6
- 238000001514 detection method Methods 0.000 title description 11
- 239000000126 substance Substances 0.000 title description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims description 6
- 229940025084 amphetamine Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 4
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 claims description 4
- 229930003827 cannabinoid Natural products 0.000 claims description 4
- 239000003557 cannabinoid Substances 0.000 claims description 4
- 229940065144 cannabinoids Drugs 0.000 claims description 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 4
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical group OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 claims description 3
- 229940049706 benzodiazepine Drugs 0.000 claims description 3
- 229960001252 methamphetamine Drugs 0.000 claims description 3
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims description 3
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical group CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 claims description 2
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical group [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 claims description 2
- 229910001981 cobalt nitrate Inorganic materials 0.000 claims description 2
- 229960002179 ephedrine Drugs 0.000 claims description 2
- 229960002200 flunitrazepam Drugs 0.000 claims description 2
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 claims description 2
- 229960003908 pseudoephedrine Drugs 0.000 claims description 2
- 239000010902 straw Substances 0.000 claims 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims 1
- INDBQWVYFLTCFF-UHFFFAOYSA-L cobalt(2+);dithiocyanate Chemical group [Co+2].[S-]C#N.[S-]C#N INDBQWVYFLTCFF-UHFFFAOYSA-L 0.000 claims 1
- 229960003529 diazepam Drugs 0.000 claims 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 claims 1
- 238000005070 sampling Methods 0.000 claims 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 3
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Description
Page 1 Description DESCRIPTION FIELD OF INVENTION [0001] The analysis device for beverages described herein relates to the detection of drugs of abuse. More particularly, the invention relates to the uptake of a liquid sample from a beverage by capillary force, and subjects the liquid sample to an analytical system which performs a visible qualitative color assay in the presence of drugs of abuse.
BACKGROUND OF THE INVENTION [0002] The clandestine placement of drugs into drinks has occurred for many years. Recently in both Australia and the United States of America this activity has focused its attention on a crime that has become known as Date Rape. The perpetrators of this crime are reportedly approaching their victims at social gatherings, bars, clubs and the like and placing various chemicals into beverages which are subsequently consumed by the unknowing victim. Sedation may occur within 20-30 minutes and last for several hours. Reports of young women waking up in unfamiliar surroundings, without clothes, have been reported in the USA. Along with these reports the all too familiar chemical names flunitrazepam, also known as rohypnol (roofies, roche, ruffles, R-2, rib, rope) and gamma hydroxy butuyrate (blue nitro, liquid ecstasy, fantasy, GBH) have become synonymous with Date Rape. This is however misleading, as Australian Forensic testing reports implicate methylamphetamine, amphetamine, MDMA (ecstasy) and cannabinoids as the drugs of choice for clandestine placement in beverages.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS [0003] Described herein is a device for the rapid, easy, safe, inexpensive and reliable detection of drugs of abuse in beverages. Detection is necessary in order to prevent a person consuming a drink that has been spiked without their knowledge. These drugs can include but are not limited to ephedrine, pseudoephedrine, methylamphetamine, amphetamine, MDMA, benzodiazepines, GHB, ketamine, and cannabinoids. The testing of drugs of abuse is comprehensive and well documented in literature. Many of the techniques for drug detection however are costly, complicated or require well trained personnel and equipped laboratories. It is not the intention of the current invention to identify individual drugs of abuse, rather, to alert the user to the possibility of a narcotic or impurity being present within their beverage. This is observed as a presumptive color change in the bibulous carrier when contacted with a spiked beverage sample.
[0004] Detection of amphetamine type drugs and benzodiazepines may be achieved with modified Dragendorffs reagent. [0005] Detection of benzodiazipines may be achieved with Page la Zimmerman?s reagent. [0006] Detection of amphetamine type drugs and GHB may be achieved with bromocresol green. [0007] Detection of amphetamine type drugs may be achieved with cobalt thiocynate. [0008] Detection of GHB may be achieved with cobalt nitrate. [0009] Detection of cannabinoids may be achieved with Duquenois-Levine reagent. [0010] These are provided by way of example and are in no way intended to limit the scope of the invention.
[0011] While the invention has been described in its preferred embodiment with some degree of specificity, it is understood that these details have been given by way of example and changes in construction and chemical design may be made without departing from the spirit and scope of the invention.
Claims (14)
1. A device for detecting the presence of drugs of abuse in a beverage comprising: a. a manufactured plastic capillary tube for beverage sampling. b. a manufactured bibulous carrier. c. colorimetric reagents pre-impregnated into bibulous carrier.
2. The device of claim 1. where said drugs of abuse is a benzodiazepine diazepam, flunitrazepam, etc)
3. The device of claim 1. where said drugs of abuse includes, but not restricted to, ephedrine, pseudoephedrine, methylamphetamine, amphetamine, methylenedioxymethylamphetamine (MDMA).
4. The device of claim 1. where said drugs of abuse is Gamma-hydroxybutyrate (GHB). The device of claim 1. where said drugs of abuse are cannabinoids.
6. The device of claim 1. where said manufactured plastic capillary tube is a straw or straw like device on thin internal diameter.
7. The device of claim 1. where said manufactured bibulous carrier is filter paper (Whatmann No.l, No.2 or No.3).
8. The device of claim 1. where said colorimetric reagent is Dragendorff?s reagent.
9. The device of claim 1. where said colorimetric reagent is Zimmerman?s reagent. The device of claim 1. where said colorimetric reagent is bromocresol green.
11. The device of claim 1. where said colorimetric reagent is cobalt thiocyanate.
12. The device of claim 1. where said colorimetric reagent is cobalt nitrate.
13. The device of claim 1. where said colorimetric reagent is Duquenois-Levine reagent.
14. A method for testing for the presence of drugs of abuse in a beverage which requires: a. Obtaining a sample volume of the beverage solution. b. Spotting the beverage sample volume onto the test bibulous carrier. c. Observing a colorimetric change of the test bibulous carrier. The method of claim 14. where said sample volume is no more than one fifth of one millilitre.
16. The method of claim 14 where said spotting of sample volume is achieved by applying and removing the plastic capillary rapidly three times onto the surface of the bibulous carrier. Page 3
17. The method of claim 14 where said colorimetric change is easily visible in natural light and occurs within seconds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003100271A AU2003100271A4 (en) | 2003-04-13 | 2003-04-13 | Chemical spot test for the detection of drugs of abuse in a beverage. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003100271A AU2003100271A4 (en) | 2003-04-13 | 2003-04-13 | Chemical spot test for the detection of drugs of abuse in a beverage. |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003100271A4 true AU2003100271A4 (en) | 2003-07-10 |
Family
ID=39246757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003100271A Ceased AU2003100271A4 (en) | 2003-04-13 | 2003-04-13 | Chemical spot test for the detection of drugs of abuse in a beverage. |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2003100271A4 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008017127A1 (en) * | 2006-08-10 | 2008-02-14 | A Capital Idea (Act) Pty Ltd | A method for detecting a pharmaceutically active agent |
CN102213719A (en) * | 2010-04-02 | 2011-10-12 | 北京库尔科技有限公司 | Flunitrazepam detection kit and preparation method thereof |
EP2200972A4 (en) * | 2007-08-30 | 2013-05-29 | Mistral Detection Ltd | A reagent, a kit, and a method for detecting and identifying a wide range of illicit drugs |
WO2016009182A1 (en) * | 2014-07-15 | 2016-01-21 | Cyd & Cyd Limited | Portable method for the detection of drugs |
US10330603B1 (en) | 2016-04-08 | 2019-06-25 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents |
-
2003
- 2003-04-13 AU AU2003100271A patent/AU2003100271A4/en not_active Ceased
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008017127A1 (en) * | 2006-08-10 | 2008-02-14 | A Capital Idea (Act) Pty Ltd | A method for detecting a pharmaceutically active agent |
EP2200972A4 (en) * | 2007-08-30 | 2013-05-29 | Mistral Detection Ltd | A reagent, a kit, and a method for detecting and identifying a wide range of illicit drugs |
CN102213719A (en) * | 2010-04-02 | 2011-10-12 | 北京库尔科技有限公司 | Flunitrazepam detection kit and preparation method thereof |
WO2016009182A1 (en) * | 2014-07-15 | 2016-01-21 | Cyd & Cyd Limited | Portable method for the detection of drugs |
US10330603B1 (en) | 2016-04-08 | 2019-06-25 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010200482B2 (en) | Sample collection cup with integrated sample analysis system | |
Kapur | Drug testing methods and interpretations of test results | |
US6537823B1 (en) | Method for detection of bromine in urine using liquid chemistry dry chemistry test pads and lateral flow | |
WO2001038873A3 (en) | Devices and methods for detecting analytes using electrosensor having capture reagent | |
WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
US20100210033A1 (en) | Portable device for detecting food allergens | |
Kelley-Baker et al. | Comparing drug detection in oral fluid and blood: data from a national sample of nighttime drivers | |
US20030044989A1 (en) | Apparatus and method for testing a beverage for a clandestine illicit substance | |
Gjerde et al. | Comparison of drugs used by nightclub patrons and criminal offenders in Oslo, Norway | |
AU2003100271A4 (en) | Chemical spot test for the detection of drugs of abuse in a beverage. | |
WO2001059157A2 (en) | Process for the enumeration and identification of microorganisms | |
Leino et al. | Comparison of eight commercial on-site screening devices for drugs-of-abuse testing | |
US20030045003A1 (en) | Method for detection of the adulterant urine luckTM in urine using liquid chemistry, dry chemistry test pads, and lateral flow | |
CN101995454B (en) | Detecting device and using method thereof | |
US20040248310A1 (en) | Method for detection of bromine in urine using liquid chemistry, dry chemistry test pads, and lateral flow | |
Chèze et al. | A tendency for re-offending in drug-facilitated crime | |
Christophersen et al. | Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine and related areas | |
Ataei et al. | High specificity of semi‐nested multiplex PCR using dried blood spots on DNA Banking Card in comparison with frozen liquid blood for detection of Plasmodium falciparum and Plasmodium vivax | |
Kyle et al. | Evaluating novel markers for specimen validity testing | |
US20090137049A1 (en) | Method for the presumptive detection of substances | |
Wu Chen et al. | The General Toxicology Unknown I. The Systematic Approach | |
GB2453448A (en) | Apparatus for detecting drugs in a beverage | |
Elkhateeb et al. | Influence of zinc and some commercial products on tramadol and apetryl detection in human urine samples | |
Mohr et al. | Laboratory-Based Evaluation of the DrugWipe 5 S Performance | |
EP4509837A1 (en) | Kit for detecting 25-hydroxyvitamin d in sample and detection method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK21 | Patent ceased section 101c(b)/section 143a(c)/reg. 9a.4 - examination under section 101b had not been carried out within the period prescribed |